|
1.
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
2.
|
Greenlee RT, Murray T, Bolden S and Wingo
PA: Cancer statistics, 2000. CA Cancer J Clin. 50:7–33. 2000.
View Article : Google Scholar
|
|
3.
|
Yin W, Cheng W, Shen W, et al: Impairment
of Na(+),K(+)-ATPase in CD95(APO-1)-induced human T-cell leukemia
cell apoptosis mediated by glutathione depletion and generation of
hydrogen peroxide. Leukemia. 21:1669–1678. 2007.
|
|
4.
|
Einbond LS, Shimizu M, Ma H, et al: Actein
inhibits the Na+-K+-ATPase and enhances the
growth inhibitory effect of digitoxin on human breast cancer cells.
Biochem Biophys Res Commun. 375:608–613. 2008.PubMed/NCBI
|
|
5.
|
Prassas I and Diamandis EP: Novel
therapeutic applications of cardiac glycosides. Nat Rev Drug
Discov. 7:926–935. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
6.
|
Haux J: Digitoxin is a potential
anticancer agent for several types of cancer. Med Hypotheses.
53:543–548. 1999. View Article : Google Scholar : PubMed/NCBI
|
|
7.
|
Xu ZW, Wang FM, Gao MJ, et al: Cardiotonic
steroids attenuate ERK phosphorylation and generate cell cycle
arrest to block human hepatoma cell growth. J Steroid Biochem Mol
Biol. 125:181–191. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8.
|
Klymkowsky MW and Savagner P:
Epithelial-mesenchymal transition: a cancer researcher’s conceptual
friend and foe. Am J Pathol. 174:1588–1593. 2009.PubMed/NCBI
|
|
9.
|
Peng CW, Liu XL, Liu X and Li Y:
Co-evolution of cancer microenvironment reveals distinctive
patterns of gastric cancer invasion: laboratory evidence and
clinical significance. J Transl Med. 8:1012010. View Article : Google Scholar
|
|
10.
|
Thiery JP, Acloque H, Huang RY and Nieto
MA: Epithelial-mesenchymal transitions in development and disease.
Cell. 139:871–890. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
11.
|
Espinosa-Neira R, Mejia-Rangel J,
Cortes-Reynosa P and Salazar EP: Linoleic acid induces an EMT-like
process in mammary epithelial cells MCF10A. Int J Biochem Cell
Biol. 43:1782–1791. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
12.
|
Kim MA, Lee HS, Lee HE, Kim JH, Yang HK
and Kim WH: Prognostic importance of epithelial-mesenchymal
transition-related protein expression in gastric carcinoma.
Histopathology. 54:442–451. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
13.
|
Joost S, Almada LL, Rohnalter V, et al:
GLI1 inhibition promotes epithelial-to-mesenchymal transition in
pancreatic cancer cells. Cancer Res. 72:88–99. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
14.
|
Walker S: Updates in non-small cell lung
cancer. Clin J Oncol Nurs. 12:587–596. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
15.
|
Shintani Y, Okimura A, Sato K, et al:
Epithelial to mesenchymal transition is a determinant of
sensitivity to chemoradiotherapy in non-small cell lung cancer. Ann
Thorac Surg. 92:1794–1804. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16.
|
Hardy KM, Booth BW, Hendrix MJC, Salomon
DS and Strizzi L: ErbB/EGF signaling and EMT in mammary development
and breast cancer. J Mammary Gland Biol Neoplasia. 15:191–199.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
17.
|
Wu K and Bonavida B: The activated
NF-kappaB-Snail-RKIP circuitry in cancer regulates both the
metastatic cascade and resistance to apoptosis by cytotoxic drugs.
Crit Rev Immunol. 29:241–254. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
18.
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
19.
|
Mariotti A, Perotti A, Sessa C and Rüegg
C: N-cadherin as a therapeutic target in cancer. Expert Opin
Investig Drugs. 16:451–465. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
20.
|
Wheelock MJ, Shintani Y, Maeda M, Fukumoto
Y and Johnson KR: Cadherin switching. J Cell Sci. 121:727–735.
2008. View Article : Google Scholar : PubMed/NCBI
|
|
21.
|
Kokkinos MI, Wafai R, Wong MK, Newgreen
DF, Thompson EW and Waltham M: Vimentin and epithelial-mesenchymal
transition in human breast cancer - observations in vitro and in
vivo. Cells Tissues Organs. 185:191–203. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22.
|
Uddin MN, Horvat D, Glaser SS, et al:
Marinobufagenin inhibits proliferation and migration of
cytotrophoblast and CHO cells. Placenta. 29:266–273. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
23.
|
Huang CY, Lin CY, Tsai CW and Yin MC:
Inhibition of cell proliferation, invasion and migration by ursolic
acid in human lung cancer cell lines. Toxicol In Vitro.
25:1274–1280. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
24.
|
Hua H, Li M, Luo T, Yin Y and Jiang Y:
Matrix metalloproteinases in tumorigenesis: an evolving paradigm.
Cell Mol Life Sci. 68:3853–3868. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
25.
|
Lin CY, Tsai PH, Kandaswami CC, et al:
Matrix metalloproteinase-9 cooperates with transcription factor
Snail to induce epithelial-mesenchymal transition. Cancer Sci.
102:815–827. 2011. View Article : Google Scholar : PubMed/NCBI
|
